期刊文献+

格列美脲联合胰岛素治疗2型糖尿病的临床研究 被引量:10

下载PDF
导出
摘要 目的:探讨格列美脲联合胰岛素治疗2型糖尿病的临床疗效。方法:对122例2型糖尿病患者采取不同的方案进行治疗,观察组应用格列美脲联合胰岛素,对照组仅应用胰岛素进行治疗,两组患者均给予糖尿病健康教育,制定科学、合理的营养饮食,指导、督促长期坚持体育锻炼等。对比两组患者治疗前后空腹血糖(FBG)、餐后2h血糖(2hBG)、体重指数(BMI)及糖化血红蛋白(HbA1c)等指标,评价格列美脲的应用价值。结果:观察组达标率以及FBG、2hBG、HbA1c几项指标的变化情况与对照组相比均具有明显的优势,整体疗效较好,且无严重不良反应发生。结论:格列美脲联合胰岛素治疗2型糖尿病,能够获得较单一应用胰岛素更为满意的临床疗效,是值得推广的治疗方案。
出处 《中国医学创新》 CAS 2012年第18期106-107,共2页 Medical Innovation of China
  • 相关文献

参考文献5

二级参考文献14

  • 1颜云湘.第3代磺脲类抗糖尿病药——格列美脲片[J].中国临床药学杂志,2006,15(5):334-335. 被引量:48
  • 2田蕾,黄一玲,华潞,蒋娟娟,李一石.格列美脲及其活性代谢物羟基格列美脲的人体药代动力学[J].中国临床药理学与治疗学,2006,11(8):868-872. 被引量:15
  • 3McKeage K,Goa KL.Insulin glargine:a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus[J].Drugs,2001,61(11):1599-1624.
  • 4Hamann A,Matthaei S,Rosak C,et al.A randomized clinical trical comparing breakfast dinner or bedtime administration of insulin glargine in patients with type 1[J].Diabetes Care,2003,26(6):1738-1744.
  • 5Rosenstock J,Schwartz SL,Clark CM,et al.Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine(HOE901)and NPH insulin[J].Diabetes Care,2001,24(4):631-636.
  • 6Raptis SA,Hatziagelaki E,Dimitriadis G,et al.Comparative effects ofglimepiride and glibendamide on blood glucose,C-peptide and insulin concentrations of the fasting and postprandial state in normal men[J].Exp Clin Endocrinol diabet,1999,107(6):350-355.
  • 7Rosenstock J,Dailey G.Massi-BenedettiM,et al.Reduced hypoglycemia risk with insulin glargine:a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes[J].Diabetes Care,2005,28:950-995.
  • 8Janka HU,Raddh MC,Plewe G,et al.Comparison of basal insulin added to oral agents versus twice-daily permixed insulin as initial insulin therapy for type 2 diabetes[J].Diabetes Care,2005,28:254-259.
  • 9Korytkowski M,Thomas A,Reid L,et al.Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes[J].Diabetes Care,2002,25:1607-1611.
  • 10Simeonov SB, Botushanov NP, Iliev DA, et al. Amaryl (Glimepiride) in patients with type 2 diabetes mellitus. Folia Med ,2002,44 : 15-19.

共引文献45

同被引文献75

  • 1范泉,蔡连玲,李秀娟,王永亮,董作佳,陈海梅.格列美脲联合诺和锐30治疗老年肥胖2型糖尿病的疗效观察[J].实用老年医学,2013,27(2):135-137. 被引量:9
  • 2颜云湘.第3代磺脲类抗糖尿病药——格列美脲片[J].中国临床药学杂志,2006,15(5):334-335. 被引量:48
  • 3田蕾,黄一玲,华潞,蒋娟娟,李一石.格列美脲及其活性代谢物羟基格列美脲的人体药代动力学[J].中国临床药理学与治疗学,2006,11(8):868-872. 被引量:15
  • 4黄秋霞,杜巍,刘玉华.亚莫利对初诊2型糖尿病患者血糖、血脂、胰岛素抵抗和纤溶活性的影响[J].中国动脉硬化杂志,2007,15(7):506-508. 被引量:9
  • 5Bando K, YamadaY.Glimepiride(Amaryl):a review of its pharmacological and clinical profile[J].Nippon Yakurigaku Zasshi, 2001,118 ( 1 ) : 59-67.
  • 6Raptis SA, Hatziagelaki E, Dimitriadis G, et al.comparative effects of glimepiride and glibenclamide on blood glucose,C-peptide and insulin concentrations of the fasting and postprandial state in normal men[J].Exp Clin Endocrinol Diabet, 1999,107 ( 6 ) : 350-355.
  • 7Masafumi K, Jun M, Shinya M, et al. Comparison of annual variabil- ity in HbA1 c and glycated albumin in patients with type 1 vs. type 2 diabetes mellitus[ J]. Journal of Diabetes and its Complications, 2013,27(3) :211 -213.
  • 8Charles SV, Josanne V, Michel M, et al. A composite risk assess- ment model to screen for gestational diabetes mellitus among Medi- terranean women[ J]. International Journal of Gynecology & Obstet- rics, 2013,120 ( 3 ) : 240 - 244.
  • 9Sotero PR,Jose LA,Antonio GE,et al. Metformin therapy and prog- nosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community [ J ]. International Journal of Cardiology, 2013,166 ( 2 ) :404 - 412.
  • 10Sire eonov SB, Botushanov NP, Iliev DA, et a.l Amaryl(G limepiride) in patients with type 2 diabetesmeUitus [J].Fo- 1laMed, 2002(44):15-19.

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部